Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Herbert J. Zeh"'
Autor:
Pranav Murthy, Aatur D. Singhi, Mark A. Ross, Patricia Loughran, Pedram Paragomi, Georgios I. Papachristou, David C. Whitcomb, Amer H. Zureikat, Michael T. Lotze, Herbert J. Zeh III, Brian A. Boone
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Background: Neutrophil extracellular traps (NETs) are generated when activated neutrophils, driven by PAD4, release their DNA, histones, HMGB1, and other intracellular granule components. NETs play a role in acute pancreatitis, worsening pancreatic i
Externí odkaz:
https://doaj.org/article/2f246b1f618e4df2a01e34b810a99c8b
Autor:
Michael T. Lotze, Mark A. Ross, Georgios I. Papachristou, Patricia Loughran, Aatur D. Singhi, Brian A. Boone, Pedram Paragomi, Pranav Murthy, Amer H. Zureikat, David C. Whitcomb, Herbert J. Zeh
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 10 (2019)
Frontiers in Immunology, Vol 10 (2019)
Background: Neutrophil extracellular traps (NETs) are generated when activated neutrophils, driven by PAD4, release their DNA, histones, HMGB1, and other intracellular granule components. NETs play a role in acute pancreatitis, worsening pancreatic i
Autor:
Nathan Bahary, Mark E. Bernard, Herbert J. Zeh, Dwight E. Heron, Steven A. Burton, Philip A. Sutera, Hong Wang
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Frontiers in Oncology
Frontiers in Oncology
Introduction Pancreatic adenocarcinoma is an aggressive malignancy that has consistently demonstrated poor outcomes despite aggressive treatments. Despite multimodal treatment, local disease progression and local recurrence are common. Management of
Autor:
Kimmen Quan, Steven A. Burton, Herbert J. Zeh, Dwight E. Heron, Nathan Bahary, Mark E. Bernard, Beant S. Gill, Kamran K. Harper, Philip A. Sutera
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 7 (2017)
Frontiers in Oncology, Vol 7 (2017)
Background/introduction Early reports of stereotactic body radiation therapy (SBRT) for pancreatic ductal adenocarcinoma (PDAC) used single fraction, but eventually shifted to multifraction regimens. We conducted a single institution review of our pa